Literature DB >> 11160605

Evidence for inducible nitric-oxide synthase expression and activity in vascular smooth muscle of streptozotocin-diabetic rats.

A L Bardell1, K M MacLeod.   

Abstract

Experiments were performed to investigate whether nitric-oxide synthase (NOS) activity can be detected in vascular smooth muscle (VSM) from 12- to 14-week streptozotocin (STZ)-diabetic rats. Concentration-response curves to norepinephrine (NE) of superior mesenteric arteries from diabetic and age- and gender-matched control rats were obtained in the presence of dexamethasone (0.1 microM) to prevent in vitro induction of iNOS. Incubation of endothelium-intact arteries from diabetic rats with the nonselective NOS inhibitor, N(5)-(1-iminoethyl)L-ornithine (L-NIO) (300 microM), increased the NE sensitivity (expressed as the pD2 or -log EC50) from 6.58 +/- 0.05 to 8.39 +/- 0.12 (mean +/- S.E.M., n = 8). L-NIO produced a significantly smaller increase in the NE pD2 value in endothelium-intact arteries from control rats (from 6.51 +/- 0.03 to 7.08 +/- 0.03, p < 0.05). On endothelium removal, L-NIO still increased the NE pD2 value in diabetic arteries, from 7.48 +/- 0.03 to 8.38 +/- 0.15 (p < 0.05), but had no effect in control arteries. The selective iNOS inhibitor S-ethylisothiourea (EIT), but not the selective nNOS inhibitor 7-nitroindazole (7-NINA), produced an increase in the NE pD2 value in endothelium-denuded mesenteric arteries from diabetic but not control rats. Immunohistochemical staining indicated the presence of iNOS (but not eNOS or nNOS) in the medial and adventitial layers of mesenteric arteries from diabetic but not control rats. Quantitative measurement of cytosolic NOS activity indicated no significant calcium-dependent (nNOS) activity in control or diabetic arteries, or calcium-independent (iNOS) activity in control arteries. However, significant calcium-independent (iNOS) activity was detected in diabetic arteries. These data suggest that iNOS is functionally expressed in VSM of arteries from 12- to 14-week STZ-diabetic rats. The possible causes and consequences of the iNOS induction are discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11160605

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  18 in total

1.  Interplay between the kinin B1 receptor and inducible nitric oxide synthase in insulin resistance.

Authors:  Youssef Haddad; Réjean Couture
Journal:  Br J Pharmacol       Date:  2016-05-06       Impact factor: 8.739

2.  Comparison of the effects of vasopressin and norepinephrine on organ perfusion during septic shock in streptozotocin-induced diabetic rats.

Authors:  Hiroshi Hinohara; Yuji Kadoi; Aya Tokue; Shigeru Saito; Chikara Kawauchi; Akio Mizutani
Journal:  J Anesth       Date:  2010-08       Impact factor: 2.078

3.  Endothelial cell transfusion ameliorates endothelial dysfunction in 5/6 nephrectomized rats.

Authors:  Maricica Pacurari; Dongqi Xing; Rob H P Hilgers; Yuan Yuan Guo; Zhengqin Yang; Fadi G Hage
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-08-16       Impact factor: 4.733

4.  Sex differences in mesenteric endothelial function of streptozotocin-induced diabetic rats: a shift in the relative importance of EDRFs.

Authors:  Rui Zhang; Der Thor; Xiaoyuan Han; Leigh Anderson; Roshanak Rahimian
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-09-14       Impact factor: 4.733

5.  Endothelial dysfunction in mice with streptozotocin-induced type 1 diabetes is opposed by compensatory overexpression of cyclooxygenase-2 in the vasculature.

Authors:  Carmela Nacci; Mariela Tarquinio; Leonarda De Benedictis; Annamaria Mauro; Addolorata Zigrino; Maria Rosaria Carratù; Michael J Quon; Monica Montagnani
Journal:  Endocrinology       Date:  2008-10-09       Impact factor: 4.736

6.  Contribution of nitric oxide produced by inducible nitric oxide synthase to vascular responses of mesenteric arterioles in streptozotocin-diabetic rats.

Authors:  Tomohisa Ishikawa; Fumika Kohno; Ryosuke Kawase; Yuri Yamamoto; Koichi Nakayama
Journal:  Br J Pharmacol       Date:  2004-01-05       Impact factor: 8.739

Review 7.  Advanced lipid peroxidation end products in oxidative damage to proteins. Potential role in diseases and therapeutic prospects for the inhibitors.

Authors:  A Negre-Salvayre; C Coatrieux; C Ingueneau; R Salvayre
Journal:  Br J Pharmacol       Date:  2007-07-23       Impact factor: 8.739

8.  Inducible nitric oxide synthase mediates retinal DNA damage in Goto-Kakizaki rat retina.

Authors:  Izumi Yuasa; Ning Ma; Hisashi Matsubara; Yoshihiro Fukui; Yukitaka Uji
Journal:  Jpn J Ophthalmol       Date:  2008-09-05       Impact factor: 2.447

9.  Dietary coconut kernel protein beneficially modulates NFκB and RAGE expression in streptozotocin induced diabetes in rats.

Authors:  G Salil; R Nithya; K G Nevin; T Rajamohan
Journal:  J Food Sci Technol       Date:  2012-05-11       Impact factor: 2.701

10.  Selective inhibition of protein kinase C beta(2) attenuates inducible nitric oxide synthase-mediated cardiovascular abnormalities in streptozotocin-induced diabetic rats.

Authors:  Prabhakara Reddy Nagareddy; Hesham Soliman; Guorong Lin; Padmesh S Rajput; Ujendra Kumar; John H McNeill; Kathleen M MacLeod
Journal:  Diabetes       Date:  2009-07-08       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.